Identify relevant clinical trials and pre-screen your patients within minutes. Use our secure platform to directly connect with clinical research teams and find new treatment options for your patient.
myTomorrows simplifies the process of identifying clinical trials, pre-screening patients against eligibility criteria, and connecting with recruiting trial sites.
Our advanced search engine, paired with AI-assisted pre-screening, provides an instant overview of relevant trial options and our GPDR-compliant and ISO27001-certified platform allows you to securely connect with site staff to discuss your patient’s medical profile.
myTomorrows is completely free-of-charge to patients and physicians, and our dedicated Medical Community team is here to support you every step of the way.
We’ve helped
With a community of
Across
Use our free service to seamlessly identify, pre-screen, and connect your patients with relevant clinical trial options.
Access a global search engine that covers active clinical trials across 200+ countries, drawing from trusted sources like ClinicalTrials.gov, EU Clinical Trials, and ISRCTN.
Instantly assess patient eligibility with an integrated AI pre-screening tool that suggests relevant trial options based on your patient’s unique medical profile.
Discuss your patient’s medical profile with recruiting trial sites using a secure GDPR-compliant and ISO-27001 certified chat and file sharing platform.
Dr. Adam Fullagar
Clinical Oncologist, Royal Stoke Hospital
Neurologist
Italy
Oncology Researcher
United Kingdom
With myTomorrows, navigating clinical trial options has never been more straightforward. Our platform eliminates the complexities of trial matching, allowing you to quickly find, evaluate, and connect with recruiting sites in just a few clicks. Built to support you and your patients at every stage, our secure and easy-to-use platform ensures you spend less time on research and more on patient care.
myTomorrows is a global healthtech company on a mission to break down barriers for patients and physicians seeking pre-approval treatment options. Our platform and services are therefore always free of charge to patients and physicians.
We work with BioPharma companies to support clinical trial recruitment and manage international expanded access programs, logistics, quality management, distribution, and real-world data collection.
We ensure free and agnostic access to information about all potential pre-approval options, regardless of our collaborations with BioPharma companies.
myTomorrows prioritizes patient privacy by ensuring that medical information is handled only with explicit patient consent and for a specific processing purpose. Our platform is both GDPR-compliant and ISO 27001-certified, providing a secure environment for processing sensitive data. Where local law permits, treating physicians can also securely upload and share patient records directly within the platform, but only after the patient’s explicit consent.
myTomorrows supports any disease areas where there is a high unmet medical need, such as oncology, rare diseases, and genetic diseases. Examples of disease areas include neuromuscular diseases (incl. Duchenne muscular dystrophy, myotonic dystrophy etc.), type 1 diabetes, brain cancer, and lung cancer.
